Showing results (1081-1090 of 1,221) with videos related to
Sort By:
Pageof 123
Progress in Community Health Partnerships : Research, Education, and Action|June 29, 2026
Building a Community Partnership to Meet the Needs of Parents of Neurodivergent ChildrenElyse R Park, Brett Goshe, Isabelle Miranda, et al.Cell Death & Disease|May 25, 2013
Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signalsH-M Yun, J H Oh, J-H Shim, et al.Cancer|August 1, 2013
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupLarry L Wang, Rie Suganuma, Naohiko Ikegaki, et al.European Journal of Cancer (Oxford, England : 1990)|December 30, 2016
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group ProjectMark A Applebaum, Zalman Vaksman, Sang Mee Lee, et al.Transplantation and Cellular Therapy|March 26, 2023
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia PatientsAnurekha G Hall, Lena E Winestone, Erin M Sullivan, et al.Global Advances in Integrative Medicine and Health|May 15, 2026
Feasibility and Acceptability of Group-Based Interventions (Offered in English and Spanish) for Caregivers of Children With LADElyse R Park, Brett M Goshe, Isabelle Miranda, et al.Neuroinformatics|March 27, 2004
Informatics center for mouse genomics: the dissection of complex traits of the nervous systemGlenn D Rosen, Nathan T La Porte, Boris Diechtiareff, et al.Pediatric Blood & Cancer|November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group StudyEsther R Berko, Arlene Naranjo, Alexander A Daniels, et al.British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.Pageof 123